A dopamine agonist used for the treatment of Parkinson’s disease between 1989 and 2007. It was withdrawn from use in the U.S. in 2007 because of observed cardiac side effects (valvular heart disease and cardiac fibrosis).
« Back to Glossary Index
« Back to Glossary Index